BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 11490159)

  • 21. Analysis of tumor-infiltrating gamma delta T cells in rectal cancer.
    Rong L; Li K; Li R; Liu HM; Sun R; Liu XY
    World J Gastroenterol; 2016 Apr; 22(13):3573-80. PubMed ID: 27053849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antilymphoma activity of human gamma delta T-cells in mice with severe combined immune deficiency.
    Malkovska V; Cigel FK; Armstrong N; Storer BE; Hong R
    Cancer Res; 1992 Oct; 52(20):5610-6. PubMed ID: 1394184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of tumor reactivity of human V gamma 9V delta 2 gamma delta T cells in vitro and in SCID mice in vivo.
    Kabelitz D; Wesch D; Pitters E; Zöller M
    J Immunol; 2004 Dec; 173(11):6767-76. PubMed ID: 15557170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-γδ TCR antibody-expanded γδ T cells: a better choice for the adoptive immunotherapy of lymphoid malignancies.
    Zhou J; Kang N; Cui L; Ba D; He W
    Cell Mol Immunol; 2012 Jan; 9(1):34-44. PubMed ID: 21666706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adoptively transferred ex vivo expanded gammadelta-T cells mediate in vivo antitumor activity in preclinical mouse models of breast cancer.
    Beck BH; Kim HG; Kim H; Samuel S; Liu Z; Shrestha R; Haines H; Zinn K; Lopez RD
    Breast Cancer Res Treat; 2010 Jul; 122(1):135-44. PubMed ID: 19763820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor antigen pulsed dendritic cells enhance the cytolytic activity of tumor infiltrating lymphocytes in human hepatocellular cancer.
    Friedl J; Stift A; Paolini P; Roth E; Steger GG; Mader R; Jakesz R; Gnant MF
    Cancer Biother Radiopharm; 2000 Oct; 15(5):477-86. PubMed ID: 11155819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation of antitumor-specific cytotoxic T lymphocytes from autologous tumor infiltrating lymphocytes in non-Hodgkin's lymphomas.
    Chaperot L; Delfau-Larue MH; Jacob MC; Molens JP; Roussel B; Agrawal S; Farcet JP; Gressin R; Sotto JJ; Bensa JC; Plumas J
    Exp Hematol; 1999 Jul; 27(7):1185-93. PubMed ID: 10390194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL6 Induces an IL22
    St Paul M; Saibil SD; Lien SC; Han S; Sayad A; Mulder DT; Garcia-Batres CR; Elford AR; Israni-Winger K; Robert-Tissot C; Zon M; Katz SR; Shaw PA; Clarke BA; Bernardini MQ; Nguyen LT; Haibe-Kains B; Pugh TJ; Ohashi PS
    Cancer Immunol Res; 2020 Mar; 8(3):321-333. PubMed ID: 31964625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depletion of IL-10- and TGF-beta-producing regulatory gamma delta T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells.
    Seo N; Tokura Y; Takigawa M; Egawa K
    J Immunol; 1999 Jul; 163(1):242-9. PubMed ID: 10384122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer.
    Meng Q; Liu Z; Rangelova E; Poiret T; Ambati A; Rane L; Xie S; Verbeke C; Dodoo E; Del Chiaro M; Löhr M; Segersvärd R; Maeurer MJ
    J Immunother; 2016; 39(2):81-9. PubMed ID: 26849077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spleen-derived dendritic cells engineered to enhance interleukin-12 production elicit therapeutic antitumor immune responses.
    Furumoto K; Arii S; Yamasaki S; Mizumoto M; Mori A; Inoue N; Isobe N; Imamura M
    Int J Cancer; 2000 Sep; 87(5):665-72. PubMed ID: 10925360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The comparison of cytotoxic T-lymphocyte effects of dendritic cells stimulated by the folate binding protein peptide cultured with IL-15 and IL-2 in solid tumor.
    Kim DK; Kim JH; Kim YT; Kim JW; Ioannides CG
    Yonsei Med J; 2002 Dec; 43(6):691-700. PubMed ID: 12497651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effector cells of low-dose IL-2 immunotherapy in tumor bearing mice: tumor cell killing by CD8+ cytotoxic T lymphocytes and macrophages.
    Maas RA; Roest PA; Becker MJ; Weimar IS; Dullens HF; Den Otter W
    Immunobiology; 1992 Nov; 186(3-4):214-29. PubMed ID: 1490728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical application of adoptive immunotherapy by cytotoxic T lymphocytes induced from tumor-infiltrating lymphocytes].
    Yamaue H; Tanimura H; Tsunoda T; Iwahashi M; Tani M; Inoue M; Tamai M
    Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):978-89. PubMed ID: 2391445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor lysate and IL-18 loaded dendritic cells elicits Th1 response, tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma.
    Yamanaka R; Honma J; Tsuchiya N; Yajima N; Kobayashi T; Tanaka R
    J Neurooncol; 2005 Apr; 72(2):107-13. PubMed ID: 15925989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel bispecific antibodies increase γδ T-cell cytotoxicity against pancreatic cancer cells.
    Oberg HH; Peipp M; Kellner C; Sebens S; Krause S; Petrick D; Adam-Klages S; Röcken C; Becker T; Vogel I; Weisner D; Freitag-Wolf S; Gramatzki M; Kabelitz D; Wesch D
    Cancer Res; 2014 Mar; 74(5):1349-60. PubMed ID: 24448235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancing effect of tumor necrosis factor (TNF)-alpha, but not IFN-gamma, on the tumor-specific cytotoxicity of gammadeltaT cells from glioblastoma patients.
    Suzuki Y; Fujimiya Y; Ohno T; Katakura R; Yoshimoto T
    Cancer Lett; 1999 Jun; 140(1-2):161-7. PubMed ID: 10403555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. mTOR inhibition potentiates cytotoxicity of Vγ4 γδ T cells via up-regulating NKG2D and TNF-α.
    Cao G; Wang Q; Li G; Meng Z; Liu H; Tong J; Huang W; Liu Z; Jia Y; Wei J; Chi H; Yang H; Zhao L; Wu Z; Hao J; Yin Z
    J Leukoc Biol; 2016 Nov; 100(5):1181-1189. PubMed ID: 27256566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of anti-cancer and immunomodulatory effects of carnosol in a Balb/c WEHI-164 fibrosarcoma model.
    Rahnama M; Mahmoudi M; Zamani Taghizadeh Rabe S; Balali-Mood M; Karimi G; Tabasi N; Riahi-Zanjani B
    J Immunotoxicol; 2015; 12(3):231-8. PubMed ID: 25027673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anti-tumor effect of cytotoxic T lymphocytes induced by soluble antigen of ovarian carcinoma and anti-CD3 monoclonal antibody on ovarian carcinoma].
    Zhang Q; Wan Y; Zhai H
    Zhonghua Fu Chan Ke Za Zhi; 1998 Jun; 33(6):355-7. PubMed ID: 10806675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.